Covance Inc.  

(Public, NYSE:CVD)   Watch this stock  
Find more results for CVD
Feb 18 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 6.06B
P/E 33.06
Div/yield     -
EPS 3.24
Shares 56.58M
Beta     -
Inst. own 85%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 7.70% 6.88%
Operating margin 10.66% 9.25%
EBITD margin - 16.35%
Return on average assets 8.17% 7.24%
Return on average equity 12.64% 11.55%
Employees 12,501 -
CDP Score - -


210 Carnegie Ctr
PRINCETON, NJ 08540-6233
United States - Map
+1-609-4524440 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Covance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services.